| Literature DB >> 30814348 |
Zachary A Marcum1, Sarah D Hohl2, Shelly L Gray1, Doug Barthold1, Paul K Crane3, Eric B Larson4.
Abstract
We administered a mixed-method survey to 1,661 patients in a large health system to assess preferences toward antihypertensive use for dementia prevention. If a specific antihypertensive medication was shown to prevent or delay dementia, the vast majority (>90%) of respondents currently taking an antihypertensive reported that they would be willing to take that specific antihypertensive starting as early as mid-life. Concerns reported were potential side effects, lack of evidence of effectiveness, blood pressure being normal or low, and medication cost. Analysis of free-text responses revealed themes of concerns regarding evidence of effectiveness and health priorities.Entities:
Keywords: Alzheimer’s disease; antihypertensive agents; dementia; primary prevention
Year: 2019 PMID: 30814348 DOI: 10.3233/JAD-181080
Source DB: PubMed Journal: J Alzheimers Dis ISSN: 1387-2877 Impact factor: 4.472